Synergy Pharma Files Ch. 11, Bausch Health Offers $200M Bid
Biopharmaceutical company Synergy Pharmaceuticals Inc. filed for Chapter 11 in New York bankruptcy court on Wednesday, with plans to shrug off its $130 million debt load by selling itself to Bausch...To view the full article, register now.
Already a subscriber? Click here to view full article